Givaudan SA (OTCMKTS:GVDNY – Get Free Report) saw a large decrease in short interest in the month of November. As of November 15th, there was short interest totalling 400 shares, a decrease of 83.3% from the October 31st total of 2,400 shares. Based on an average daily volume of 51,300 shares, the days-to-cover ratio is currently 0.0 days.
Givaudan Price Performance
Givaudan stock traded up $0.34 during midday trading on Wednesday, reaching $87.87. The company’s stock had a trading volume of 16,918 shares, compared to its average volume of 17,605. Givaudan has a fifty-two week low of $73.36 and a fifty-two week high of $110.32. The company has a quick ratio of 0.94, a current ratio of 1.43 and a debt-to-equity ratio of 0.99. The business has a 50-day simple moving average of $97.84 and a 200-day simple moving average of $97.36.
Analyst Upgrades and Downgrades
Several equities analysts have recently issued reports on GVDNY shares. Barclays cut Givaudan from a “hold” rating to a “strong sell” rating in a research note on Friday, November 15th. Citigroup cut shares of Givaudan from a “buy” rating to a “neutral” rating in a report on Thursday, October 17th.
About Givaudan
Givaudan SA manufactures, supplies, and sells fragrance, beauty, taste, and wellbeing products to the consumer goods industry. The company operates through divisions, Fragrance & Beauty, and Taste & Wellbeing. The Fragrance & Beauty division offers fine fragrances; consumer products, such as personal, home, fabric, and oral care; fragrance ingredients; and active beauty products.
Featured Stories
- Five stocks we like better than Givaudan
- Overbought Stocks Explained: Should You Trade Them?
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- How to Invest in the Best Canadian StocksĀ
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- How to Buy Cheap Stocks Step by Step
- 2 Generic Drug Stocks Ready to Surge in 2025
Receive News & Ratings for Givaudan Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Givaudan and related companies with MarketBeat.com's FREE daily email newsletter.